Stock Quote

Regeneron Receives Emergency Use Authorization For Covid Antibody Cocktail

Regeneron Pharmaceuticals announced that the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19, received Emergency Use Authorization from the Food and Drug Administration.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.